Collagen Type I C-Telopeptide (CTx)

CTx is a blood test that measures how quickly your body is breaking down bone. Bone is constantly being broken down and rebuilt in a process called remodeling. When the breakdown happens too fast—without enough rebuilding—bones can become weaker over time. A high CTx level may suggest your bones are breaking down faster than normal, which could increase your risk of fractures. If you are taking medication for bone health, this test helps your doctor check whether the treatment is working as expected.

When elevated: Elevated CTx suggests increased osteoclast activity and accelerated bone resorption, which may be associated with increased fracture risk, metabolic bone disease, or secondary causes of bone loss. Persistently high levels despite antiresorptive therapy may indicate treatment non-adherence, inadequate dosing, or an underlying condition driving bone turnover. When low: Low or suppressed CTx levels are commonly observed in patients on antiresorptive therapy and generally indicate effective treatment response. Markedly suppressed CTx over prolonged periods has been associated with oversuppression of bone turnover, which may theoretically increase risk of atypical femoral fractures or osteonecrosis of the jaw in certain clinical contexts.

CTx reflects bone resorption rate, which can increase with high training volume, particularly in endurance sports and weight-bearing activities. Tracking CTx alongside bone formation markers helps athletes and coaches monitor whether training load supports healthy bone remodeling or creates an imbalance favoring breakdown over rebuilding—important for injury prevention and long-term skeletal resilience.